Cargando…

Cellular Origins of EGFR‐Driven Lung Cancer Cells Determine Sensitivity to Therapy

Targeting the epidermal growth factor receptor (EGFR) with tyrosine kinase inhibitors (TKIs) is one of the major precision medicine treatment options for lung adenocarcinoma. Due to common development of drug resistance to first‐ and second‐generation TKIs, third‐generation inhibitors, including osi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Fan, Liu, Jinpeng, Flight, Robert M., Naughton, Kassandra J., Lukyanchuk, Alexsandr, Edgin, Abigail R., Song, Xiulong, Zhang, Haikuo, Wong, Kwok‐Kin, Moseley, Hunter N. B., Wang, Chi, Brainson, Christine F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596110/ https://www.ncbi.nlm.nih.gov/pubmed/34622577 http://dx.doi.org/10.1002/advs.202101999

Ejemplares similares

Polycomb deficiency drives a FOXP2-high aggressive state targetable by epigenetic inhibitors
por: Chen, Fan, et al.
Publicado: (2023)

Dysregulated Polycomb Repressive Complex 2 contributes to chronic obstructive pulmonary disease by rewiring stem cell fate
por: Byrd, Aria L., et al.
Publicado: (2022)

EZH2 inhibition promotes tumor immunogenicity in lung squamous cell carcinomas
por: DuCote, Tanner J., et al.
Publicado: (2023)

EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumors to TopoII inhibitors
por: Fillmore, Christine M., et al.
Publicado: (2015)

Coordination characterization of zinc metalloproteins
por: Yao, Sen, et al.
Publicado: (2014)

CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma
por: Zhou, Jin, et al.
Publicado: (2017)

Proceedings of the Eleventh Annual UT-ORNL-KBRIN Bioinformatics Summit 2012
por: Rouchka, Eric C, et al.
Publicado: (2012)

A Computational Framework for High-Throughput Isotopic Natural Abundance Correction of Omics-Level Ultra-High Resolution FT-MS Datasets
por: Carreer, William J., et al.
Publicado: (2013)

Deriving Lipid Classification Based on Molecular Formulas
por: Mitchell, Joshua M., et al.
Publicado: (2020)

Untargeted Lipidomics of Non-Small Cell Lung Carcinoma Demonstrates Differentially Abundant Lipid Classes in Cancer vs. Non-Cancer Tissue
por: Mitchell, Joshua M., et al.
Publicado: (2021)

Scan-Centric, Frequency-Based Method for Characterizing Peaks from Direct Injection Fourier Transform Mass Spectrometry Experiments
por: Flight, Robert M., et al.
Publicado: (2022)

A less‐biased analysis of metalloproteins reveals novel zinc coordination geometries
por: Yao, Sen, et al.
Publicado: (2015)

Aberrant coordination geometries discovered in the most abundant metalloproteins
por: Yao, Sen, et al.
Publicado: (2017)

Design and Generation of MLPA Probe Sets for Combined Copy Number and Small-Mutation Analysis of Human Genes: EGFR as an Example
por: Marcinkowska, Malgorzata, et al.
Publicado: (2010)

Overcoming EGFR T790M and C797S resistance with mutant-selective allosteric inhibitors
por: Jia, Yong, et al.
Publicado: (2016)

Deregulation of a Network of mRNA and miRNA Genes Reveals That CK2 and MEK Inhibitors May Synergize to Induce Apoptosis KRAS-Active NSCLC
por: Gober, Madeline Krentz, et al.
Publicado: (2019)

Advances in gene ontology utilization improve statistical power of annotation enrichment
por: Hinderer, Eugene W., et al.
Publicado: (2019)

Origins of cellular geometry
por: Marshall, Wallace F
Publicado: (2011)

The origins of cellular life
por: Koonin, Eugene V.
Publicado: (2014)

Novel Therapeutic Anti-ADAM17 Antibody A9(B8) Enhances EGFR-TKI–Mediated Anticancer Activity in NSCLC
por: Yang, Zheng, et al.
Publicado: (2019)

Outcome of EGFR-mutated NSCLC patients with MET-driven resistance to EGFR tyrosine kinase inhibitors
por: Baldacci, Simon, et al.
Publicado: (2017)

FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth
por: Niu, Mengmeng, et al.
Publicado: (2021)

Archipiélago Gulag, 1918-1956 : ensayo de investigación literaria
por: Soljenitsyn, Alexsandr Isaevich, 1918-
Publicado: (1974)

Extracellular vesicle-based EGFR genotyping in bronchoalveolar lavage fluid
por: Liam, Chong-Kin, et al.
Publicado: (2020)

Cellular Functions Regulated by Phosphorylation of EGFR on Tyr845
por: Sato, Ken-ichi
Publicado: (2013)

CELLULAR ORIGIN OF RHEUMATOID FACTOR
por: Mellors, Robert C., et al.
Publicado: (1959)

Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma
por: Azuaje, Francisco, et al.
Publicado: (2015)

EGFR Expression in HER2-Driven Breast Cancer Cells
por: Weinberg, Florian, et al.
Publicado: (2020)

Precision immunointerception of EGFR-driven tumorigenesis for lung cancer prevention
por: Pan, Jing, et al.
Publicado: (2023)

EGFR and EGFRvIII undergo stress- and EGFR kinase inhibitor-induced mitochondrial translocalization: A potential mechanism of EGFR-driven antagonism of apoptosis
por: Cao, Xinyu, et al.
Publicado: (2011)

Origin of the vasculature supporting growth of primary patient tumor xenografts
por: Hylander, Bonnie L, et al.
Publicado: (2013)

EGFR Inhibition Strongly Modulates the Tumour Immune Microenvironment in EGFR-Driven Non-Small-Cell Lung Cancer
por: Selenz, Carolin, et al.
Publicado: (2022)

Molecular Divergence upon EGFR-TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR-Sensitizing Mutation
por: Serna-Blasco, Roberto, et al.
Publicado: (2022)

An image-based data-driven analysis of cellular architecture in a developing tissue
por: Hartmann, Jonas, et al.
Publicado: (2020)

MALT1 is required for EGFR induced NF-κB activation and contributes to EGFR-driven lung cancer progression
por: Pan, Deng, et al.
Publicado: (2015)

Structural analysis of cannabinoids against EGFR-TK leads a novel target against EGFR-driven cell lines
por: Lamtha, Thomanai, et al.
Publicado: (2022)

Co-mutations in EGFR driven non-small cell lung cancer
por: Rosell, Rafael, et al.
Publicado: (2019)

Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR‐Driven Lung Cancer
por: Huang, Mofei, et al.
Publicado: (2022)

The Molecular and Cellular Origins of Hodgkin's Disease
por: Staudt, Louis M.
Publicado: (2000)

Challenging perspectives on the cellular origins of lymphoma
por: Malcolm, Tim I. M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ll9dfrp8age5trj5u41r2i0pa7